Lundbeck parks Alzheimer's drug hope as there is no evidence it works
![Johan Luthman, head of research and development at Lundbeck | Photo: PR / Lundbeck](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13845222.ece/ALTERNATES/schema-16_9/doc7k7tk2uq9hj1h37dib27.jpg)
Pharmaceutical firm Lundbeck is hoping to avoid the costly blunders of the past, and has therefore halted one of its drug hopes meant to treat the feared brain condition known as Alzheimer’s disease. At least for the time being.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Lundbeck maps pandemic mental health impact on US residents
For subscribers